Top ASX Future Growth Stocks

A few stocks from the ASX listed companies are following a higher growth trajectory. These stocks from potential growth companies are

Telix Pharmaceuticals Limited (ASX: TLX)

Telix Pharmaceuticals Limited (ASX: TLX) delivered a robust update for the quarter ending 30 September 2024 (Q3 2024), reporting unaudited revenue of approximately US$135 million (AU$201 million). This marks a 55% year-over-year growth (Q3 2023: US$87 million) and a 9% sequential increase from Q2 2024 (US$124 million). Year-to-date revenue stands at US$374 million (AU$565 million), driven predominantly by the strong performance of Illuccix, its prostate cancer imaging agent, in the U.S. market, which contributed US$131 million (AU$195 million) for the quarter. The company reaffirmed its FY2024 revenue guidance of US$490–510 million (AU$745–776 million), representing a substantial 48–54% growth over FY2023. Telix also maintained its expectation of a 40–50% increase in R&D expenditure for the year, with investments supported by robust earnings from product sales.

Check Now - https://veye.com.au/editorial